Found: 72
Select item for more details and to access through your institution.
Identification of a new species, Candida subhashii, as a cause of peritonitis.
- Published in:
- Medical Mycology, 2009, v. 47, n. 3, p. 305, doi. 10.1080/13693780802380545
- By:
- Publication type:
- Article
Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 7, p. 1706, doi. 10.1093/jac/dks113
- By:
- Publication type:
- Article
Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 58, n. 1, p. 202, doi. 10.1093/jac/dkl152
- By:
- Publication type:
- Article
Are fluoroquinolone-susceptible isolates of <it>Streptococcus pneumoniae</it> really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 4, p. 769, doi. 10.1093/jac/dki315
- By:
- Publication type:
- Article
708. In Vitro Activity of Plazomicin vs. Clinical Isolates of Gram-Negative Bacilli, Including Aminoglycoside Nonsusceptible and Multidrug-Resistant Subsets, Recovered from Patients Across Canada as Part of the CANWARD study, 2011–2018.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S319, doi. 10.1093/ofid/ofz360.776
- By:
- Publication type:
- Article
128. Adequacy of Commonly Prescribed Antimicrobials for Empiric Coverage of Gram-Negative Bacterial Pathogens Recovered from the Bloodstream of Patients Attending Emergency Rooms in Canada: Analysis of Data from the CANWARD Study, 2007 to 2018.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S93, doi. 10.1093/ofid/ofz360.203
- By:
- Publication type:
- Article
Nontoxigenic Vibrio cholerae Septicemia in an Immunocompromised Patient.
- Published in:
- Case Reports in Infectious Diseases, 2012, p. 1, doi. 10.1155/2012/698746
- By:
- Publication type:
- Article
Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012.
- Published in:
- Canadian Journal of Microbiology, 2013, v. 59, n. 12, p. 778, doi. 10.1139/cjm-2013-0614
- By:
- Publication type:
- Article
Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.
- Published in:
- Canadian Journal of Microbiology, 2013, v. 59, n. 12, p. 778, doi. 10.1139/cjm-2013-0614
- By:
- Publication type:
- Article
Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination.
- Published in:
- Drugs, 2024, v. 84, n. 10, p. 1219, doi. 10.1007/s40265-024-02082-9
- By:
- Publication type:
- Article
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
- Published in:
- Drugs, 2022, v. 82, n. 5, p. 533, doi. 10.1007/s40265-022-01688-1
- By:
- Publication type:
- Article
Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.
- Published in:
- Drugs, 2021, v. 81, n. 2, p. 233, doi. 10.1007/s40265-020-01443-4
- By:
- Publication type:
- Article
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
- Published in:
- Drugs, 2020, v. 80, n. 3, p. 285, doi. 10.1007/s40265-020-01257-4
- By:
- Publication type:
- Article
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
- Published in:
- Drugs, 2019, v. 79, n. 3, p. 271, doi. 10.1007/s40265-019-1055-2
- By:
- Publication type:
- Article
Correction to: Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
- Published in:
- Drugs, 2018, v. 78, n. 7, p. 787, doi. 10.1007/s40265-018-0910-x
- By:
- Publication type:
- Article
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
- Published in:
- Drugs, 2018, v. 78, n. 1, p. 65, doi. 10.1007/s40265-017-0851-9
- By:
- Publication type:
- Article
Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
- Published in:
- Drugs, 2016, v. 76, n. 18, p. 1737, doi. 10.1007/s40265-016-0667-z
- By:
- Publication type:
- Article
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.
- Published in:
- Drugs, 2016, v. 76, n. 5, p. 567, doi. 10.1007/s40265-016-0545-8
- By:
- Publication type:
- Article
Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli.
- Published in:
- Drugs, 2014, v. 74, n. 1, p. 31, doi. 10.1007/s40265-013-0168-2
- By:
- Publication type:
- Article
Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination.
- Published in:
- Drugs, 2013, v. 73, n. 2, p. 159, doi. 10.1007/s40265-013-0013-7
- By:
- Publication type:
- Article
Clinical Metagenomics Is Increasingly Accurate and Affordable to Detect Enteric Bacterial Pathogens in Stool.
- Published in:
- Microorganisms, 2022, v. 10, n. 2, p. N.PAG, doi. 10.3390/microorganisms10020441
- By:
- Publication type:
- Article
New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin.
- Published in:
- Drugs, 2010, v. 70, n. 7, p. 859, doi. 10.2165/11534440-000000000-00000
- By:
- Publication type:
- Article
Antimicrobial resistance patterns of bacterial pathogens recovered from the urine of patients at Canadian hospitals from 2009 to 2020.
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 6, p. 1, doi. 10.1093/jacamr/dlac122
- By:
- Publication type:
- Article
Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007-19.
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 1, p. 1, doi. 10.1093/jacamr/dlab197
- By:
- Publication type:
- Article
Subspecies-specific sequence detection for differentiation of Mycobacterium abscessus complex.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-73607-x
- By:
- Publication type:
- Article
Compilation of 10 Years of MIRU-VNTR Data: Canadian National Tuberculosis Laboratory's Experience.
- Published in:
- Canadian Journal of Infectious Diseases & Medical Microbiology, 2022, p. 1, doi. 10.1155/2022/3505142
- By:
- Publication type:
- Article
Frequency of MCR-1-mediated colistin resistance among Escherichia coli clinical isolates obtained from patients in Canadian hospitals (CANWARD 2008-2015).
- Published in:
- CMAJ Open, 2016, v. 4, n. 4, p. E641, doi. 10.9778/cmajo.20160080
- By:
- Publication type:
- Article
Evaluation of three MALDI‐TOF mass spectrometry libraries for the identification of filamentous fungi in three clinical microbiology laboratories in Manitoba, Canada.
- Published in:
- Mycoses, 2018, v. 61, n. 10, p. 743, doi. 10.1111/myc.12800
- By:
- Publication type:
- Article
Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6245, doi. 10.3390/ijms25116245
- By:
- Publication type:
- Article
Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007–21.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 10, p. 2653, doi. 10.1093/jac/dkae272
- By:
- Publication type:
- Article
Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i26, doi. 10.1093/jac/dkad067
- By:
- Publication type:
- Article
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i8, doi. 10.1093/jac/dkad065
- By:
- Publication type:
- Article
Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011–20.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i37, doi. 10.1093/jac/dkad068
- By:
- Publication type:
- Article
Streptococcus pneumoniae serotyping and antimicrobial susceptibility: assessment for vaccine efficacy in Canada after the introduction of PCV13.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i2, doi. 10.1093/jac/dkad064
- By:
- Publication type:
- Article
Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i17, doi. 10.1093/jac/dkad066
- By:
- Publication type:
- Article
In vitro activity of sulopenem against 1880 bacterial pathogens isolated from Canadian patients with urinary tract infections (CANWARD, 2014-21).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 12, p. 3414, doi. 10.1093/jac/dkac333
- By:
- Publication type:
- Article
In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 11, p. 3035, doi. 10.1093/jac/dkac275
- By:
- Publication type:
- Article
PCV-15 and PPSV-23 coverage of invasive and respiratory tract Streptococcus pneumoniae, including MDR and XDR isolates: CANWARD 2007-20.
- Published in:
- 2022
- By:
- Publication type:
- journal article
ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18.
- Published in:
- 2021
- By:
- Publication type:
- journal article
In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv64, doi. 10.1093/jac/dkz289
- By:
- Publication type:
- Article
Characterization of MRSA in Canada from 2007 to 2016.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv55, doi. 10.1093/jac/dkz288
- By:
- Publication type:
- Article
Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011–16 study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv48, doi. 10.1093/jac/dkz287
- By:
- Publication type:
- Article
Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007–16.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv39, doi. 10.1093/jac/dkz286
- By:
- Publication type:
- Article
Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007–16 study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv32, doi. 10.1093/jac/dkz285
- By:
- Publication type:
- Article